On Oct 5, 2021 Exo Therapeutics closed a Series B round and raised $78,000,000 from 6 Dimensions Capital, BVF Partners, Casdin Capital, CRV, Morningside Venture Partners, Newpath Management, Nextech Invest, Novartis Venture Fund, Samsara BioCapital, featuring lead investors Nextech Invest.

About the company: Exo Therapeutics is located at United States, North America.

Company website: http://www.exo-therapeutics.com

Leave a Reply

Your email address will not be published. Required fields are marked *